Related Experiment Video
Updated: Jan 4, 2026

Preparation of Exosomes for siRNA Delivery to Cancer Cells
Published on: December 5, 2018
Current Perspectives of Exosomes as Therapeutic Targets and Drug Delivery Vehicles for Pancreatic Cancer
L Srinivas1, Deepthi S1, Deepak Kgk2
1Institute of Pharmacy, GITAM (Deemed to be University), Visakhapatnam, India.
Abstract:
The ever-growing interest in exosomes research is mainly due to their potential applications in health and disease, especially in therapy and diagnosis. To explore the applications of exosomes in the clinical setting, we must understand their characteristics at the molecular levels. Furthermore, exosomes are cell and function specific; therefore, we must ascertain the molecular mechanisms of their biogenesis, cellular recognition, and uptake. In the recent past, engineered exosomes and exosome mimetics have been the subject of active research. However, critical facets of the biology of engineered exosomes and exosome mimetics remain unknown. This review presents our current understanding of the potential role of engineered exosomes and exosome mimetics in diagnosis, prognosis, monitoring of treatment, as well as drug delivery. We also present recent updates on the exosome signature, its role in pancreatic cancer progression, and applications in the delivery of natural therapeutics and RNAi molecules and in the immune response. Lastly, we discuss future prospects and challenges of exosomes in translational studies.
Insights
Exosomes hold promise for therapy and diagnosis, with engineered versions offering new avenues for drug delivery and disease monitoring. Further research into their molecular mechanisms and applications is crucial for clinical translation.
Area of Science:
- Biotechnology
- Molecular Biology
- Nanomedicine
Background:
- Exosomes are increasingly recognized for their therapeutic and diagnostic potential in various health and disease contexts.
- Understanding the molecular mechanisms of exosome biogenesis, recognition, and uptake is essential for clinical applications.
- Engineered exosomes and exosome mimetics are emerging as promising tools, but their biological aspects require further investigation.
Purpose of the Study:
- To review the current understanding of engineered exosomes and exosome mimetics.
- To explore their potential roles in diagnosis, prognosis, treatment monitoring, and drug delivery.
- To discuss recent advancements in exosome signatures, pancreatic cancer, and therapeutic delivery.
Main Methods:
- Literature review of recent studies on engineered exosomes and exosome mimetics.
- Analysis of exosome roles in pancreatic cancer progression and immune response.
- Examination of exosome applications in delivering therapeutics and RNAi molecules.
Main Results:
- Engineered exosomes and mimetics show potential in diagnostics and drug delivery.
- Exosome signatures are relevant to pancreatic cancer progression.
- Exosomes are effective carriers for natural therapeutics and RNAi molecules, influencing immune responses.
Conclusions:
- Engineered exosomes and exosome mimetics offer significant potential for clinical translation in diagnostics and therapeutics.
- Further research is needed to elucidate the biology of engineered exosomes and address challenges in translational studies.
- Exosomes represent a promising frontier in personalized medicine and targeted drug delivery systems.
Related Concept Videos
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Targeted Cancer Therapies
There are several types of targeted therapies against...

